ATE250068T1 - Thienopyran-carboxamid-derivate - Google Patents

Thienopyran-carboxamid-derivate

Info

Publication number
ATE250068T1
ATE250068T1 AT00958313T AT00958313T ATE250068T1 AT E250068 T1 ATE250068 T1 AT E250068T1 AT 00958313 T AT00958313 T AT 00958313T AT 00958313 T AT00958313 T AT 00958313T AT E250068 T1 ATE250068 T1 AT E250068T1
Authority
AT
Austria
Prior art keywords
compounds
treatment
urinary tract
lower urinary
polyfluoroalkoxy
Prior art date
Application number
AT00958313T
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Carlo Riva
Rodolfo Testa
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of ATE250068T1 publication Critical patent/ATE250068T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00958313T 1999-07-30 2000-07-28 Thienopyran-carboxamid-derivate ATE250068T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001704A IT1313581B1 (it) 1999-07-30 1999-07-30 Derivati tienopirancarbossamidici.
PCT/EP2000/007306 WO2001009140A1 (en) 1999-07-30 2000-07-28 Thienopyranecarboxamide derivatives

Publications (1)

Publication Number Publication Date
ATE250068T1 true ATE250068T1 (de) 2003-10-15

Family

ID=11383457

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00958313T ATE250068T1 (de) 1999-07-30 2000-07-28 Thienopyran-carboxamid-derivate

Country Status (22)

Country Link
EP (1) EP1200445B1 (de)
JP (1) JP2003506379A (de)
KR (1) KR100705179B1 (de)
CN (1) CN1155602C (de)
AT (1) ATE250068T1 (de)
AU (1) AU759085B2 (de)
BR (1) BR0012871A (de)
CA (1) CA2378302A1 (de)
DE (1) DE60005368T2 (de)
DK (1) DK1200445T3 (de)
ES (1) ES2206296T3 (de)
HU (1) HUP0202106A3 (de)
IL (2) IL147441A0 (de)
IT (1) IT1313581B1 (de)
MX (1) MXPA02000820A (de)
NO (1) NO20020476D0 (de)
PL (1) PL198700B1 (de)
PT (1) PT1200445E (de)
RU (1) RU2225409C2 (de)
TW (1) TWI239958B (de)
WO (1) WO2001009140A1 (de)
ZA (1) ZA200200687B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30111A1 (es) * 2006-02-03 2007-04-30 Recordati Ireland Ltd Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida
US8557807B2 (en) * 2008-01-24 2013-10-15 Signal Rx Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors
AU2014304562B8 (en) * 2013-08-08 2018-07-05 Galapagos Nv Thieno[2,3-c]pyrans as CFTR modulators
WO2018140730A1 (en) * 2017-01-27 2018-08-02 Signalrx Pharmaceuticals, Inc. Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP930210A2 (en) * 1992-02-25 1995-06-30 Recordati Chem Pharm Heterobicyclic compounds and pharmaceutical preparations containing them
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
AU9256498A (en) * 1997-08-01 1999-02-22 Recordati S.A. Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico

Also Published As

Publication number Publication date
PT1200445E (pt) 2004-02-27
DE60005368T2 (de) 2004-07-01
HUP0202106A2 (en) 2002-10-28
CA2378302A1 (en) 2001-02-08
ES2206296T3 (es) 2004-05-16
KR20020022785A (ko) 2002-03-27
AU6988200A (en) 2001-02-19
HUP0202106A3 (en) 2004-12-28
AU759085B2 (en) 2003-04-03
KR100705179B1 (ko) 2007-04-06
DK1200445T3 (da) 2004-01-12
RU2225409C2 (ru) 2004-03-10
NO20020476L (no) 2002-01-29
ITMI991704A1 (it) 2001-01-30
JP2003506379A (ja) 2003-02-18
ZA200200687B (en) 2002-10-30
ITMI991704A0 (it) 1999-07-30
WO2001009140A1 (en) 2001-02-08
DE60005368D1 (en) 2003-10-23
IL147441A (en) 2007-06-03
IL147441A0 (en) 2002-08-14
MXPA02000820A (es) 2004-03-19
PL363115A1 (en) 2004-11-15
HK1044763A1 (en) 2002-11-01
IT1313581B1 (it) 2002-09-09
EP1200445B1 (de) 2003-09-17
CN1155602C (zh) 2004-06-30
CN1365363A (zh) 2002-08-21
EP1200445A1 (de) 2002-05-02
NO20020476D0 (no) 2002-01-29
PL198700B1 (pl) 2008-07-31
TWI239958B (en) 2005-09-21
BR0012871A (pt) 2002-04-16

Similar Documents

Publication Publication Date Title
JO2503B1 (en) Benzathiazole derivatives
KR910006864B1 (ko) 종양억제제인 방향족 및 헤테로사이클릭 카복스아미드 유도체
MX9703518A (es) Dihidropirimidinas y usos de las mismas.
MY122826A (en) Dipeptide nitrile cathepsin k inhibitors
US10577337B2 (en) Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof
ATE401076T1 (de) Chinolinderivate als glucokinase liganden
WO1998051311A3 (en) Dihydropyrimidines and uses thereof
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
GC0000251A (en) Piperidine derivatives for the treatment of disorders which are associated with restenosis, glaucoma, cardiac infarct, high blood pressure and end organ damage
AR020321A1 (es) Derivados del acido antranilico, procedimiento para prepararlos, composiciones farmaceuticas formuladas con dichos derivados; uso de dichos derivados parala fabricacion de dichas composiciones y metodo para el tratamiento de enfermedades aplicando los derivados mencionados.
HK1044940A1 (zh) 異噁唑咪唑羧酰胺衍生物
WO2001094345A3 (en) Derivatives of 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
Bi et al. Quinolines as extremely potent and selective PDE5 inhibitors as potential agents for treatment of erectile dysfunction
MY144928A (en) Benzofuran derivatives
ATE357453T1 (de) Comt-inhibitoren
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
ATE389655T1 (de) Pyrimidinderivate
DK1200445T3 (da) Thienopyrancarboxamidderivater
NO20004405L (no) Farmasøytisk sammensetning for profylakse og terapi av sykdommer forbundet med okulær-fundus-vev cytopati
ATE297926T1 (de) Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen
UY26111A1 (es) Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica
EP1172360A4 (de) Neurotrophin potentiatoren
EP1806136A4 (de) Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie
HK1042090A1 (zh) N-取代的具有5-羟色胺能活性的酰亚胺衍生物
AU2003250707A1 (en) A pharmaceutical formulation and its use in the treatment of inner ear diseases

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200445

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee